1.A case of idiopathic bronchiolitis obliterans organizing pneumonia.
Cheol Whan LEE ; Youn Suck KOH ; Woo Sung KIM ; Kyeong Yub GONG ; Kun Sik SONG ; Won Dong KIM
Tuberculosis and Respiratory Diseases 1992;39(6):536-541
No abstract available.
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia*
2.Diffuse Micronodular Pattern of Bronchiolitis Obliterans Organizing Pneumonia: A Case Report.
In Jae LEE ; Seung Hun JANG ; Kwang Seon MIN ; Im Kyung WHANG ; Yul LEE ; Sang Hoon BAE
Journal of the Korean Radiological Society 2006;55(4):345-348
The typical radiographic findings of bronchiolitis obliterans organizing pneumonia (BOOP) are known to be patchy air-space consolidation that is often subpleural, and with or without ground-glass opacities. However, there are scant radiologic reports about the micronodular pattern of BOOP. We report here on a case of BOOP that manifested as diffusely scattered ill-defined centrilobular micronodules on HRCT.
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia*
3.A case of bronchiolitis obliterans organizing pneumonia associated with wheezing.
Jae Seok LEE ; Do Jin KIM ; Young Soo AHN ; Sang Moo LEE ; Hyeon Tae KIM ; Soo Taek UH ; Yong Hoon KIM ; Choon Sik PARK
Tuberculosis and Respiratory Diseases 1993;40(6):730-735
No abstract available.
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia*
;
Respiratory Sounds*
4.Development of bronchiolitis obliterans organizing pneumonia during standard treatment of hepatitis C with Peg-IFNα2b.
Eun CHUNG ; Kihoon PARK ; Jo Heon KIM ; Nam Ik HAN ; Young Sok LEE ; Si Hyun BAE ; Chung Hwa PARK
The Korean Journal of Internal Medicine 2017;32(6):1098-1100
No abstract available.
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia*
;
Hepatitis C*
;
Hepatitis*
5.Two Cases of Bronchiolitis Obliterans Organizing Pneumonia treated with Steroid and Cyclosporine therapy.
Jong Hoo LEE ; Myung Jae PARK ; Yi Hyung KIM ; Byung Jo PARK ; Won Taek OH ; Myung Yeol LEE ; Hong Mo KANG ; Jee Hong YOO
Tuberculosis and Respiratory Diseases 2005;59(3):315-320
A rapid response to corticosteroid treatment and a generally favourable outcome are characteristic features of BOOP (Bronchiolitis obliterans organizing pneumonia). However, with increasing experience of the clinical spectrum of this disease, it is now recognized that some patients are refractory to steroid, which is associated with a poor prognosis. Here, two cases of BOOP initially treated with predinisone and antibiotics without effects, but subsequently responded to secondary cyclosporine treatment, are reported.
Anti-Bacterial Agents
;
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia*
;
Cyclosporine*
;
Humans
;
Prognosis
6.Polymyositis Associated with Bronchiolitis Obliterans Organizing Pneumonia.
Woo Gyu BYEON ; Sang Soo LEE ; Kye Yeon PARK ; Seol Heui HAN ; Sung Hyun LEE ; Kang Hyun CHOI
Journal of the Korean Neurological Association 2001;19(5):547-549
Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathologic syndrome of pulmonary inflammatory responses which has become increasingly recognized and has been described in association with a variety of disorders. We present a case of polymyositis associated with BOOP that responded to a corticosteroid therapy. The patient had a nonproductive cough, increasing dyspnea, fatigue, mild proximal limb weakness, and bilateral basal interstitial infiltrates on chest X-ray. This case will add further strength to the association of BOOP with polymyositis. (J Korean Neurol Assoc 19(5):547~549, 2001)
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cough
;
Creatine Kinase
;
Cryptogenic Organizing Pneumonia*
;
Dyspnea
;
Extremities
;
Fatigue
;
Humans
;
Polymyositis*
;
Thorax
7.A Case of Bleomycin Induced Bronchiolitis Obliterans Orgnizing Pneumonia.
Hye Lim OH ; Hong Mo KANG ; Cheon Woong CHOI ; Ho Jong LEE ; Yongseun CHO ; Jee Hong YOO
Tuberculosis and Respiratory Diseases 2001;50(4):504-509
There are numerous agents with potential toxic effects on the lung. In particular, cytotoxic drugs constitute the largest and most imprtant group of agents associated with lung toxicity. Bleomycin is commonly used, either alone or in combination with other chemotherapeutic agents, in the treatment of squamous cell carcinoma(head and neck, esophagus, and genitourinary tract), lymphoma, and germ cell tumor. One of the therapeutic advantages of bleomycin is its minimal bone marrow toxicity. However, pulmonary toxicity is one of the most serous adverse side effect. Classically, pulmonary toxicity manifests as a diffuse interstitial process or less commonly as a hypersensitivity reaction. This pulmonary toxicity is generally considered to be dose related and can progress to a fatal fibrosis. It is also possible that bronchiolitis obliterans organizing pneumonia(BOOP) is another manifestation of bleomycin induced toxicity. Bleomycin induced BOOP is less common and has a favorable response to steriod therapy. Here we present a case that demonstrates a BOOP, secondary to a relatively small cumulative dose of bleomycin(225mg/??, may be reversible.
Bleomycin*
;
Bone Marrow
;
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia
;
Esophagus
;
Fibrosis
;
Hypersensitivity
;
Lung
;
Lymphoma
;
Neck
;
Neoplasms, Germ Cell and Embryonal
;
Pneumonia*
8.A Case of Bronchiolitis Obliterans Organizing Pneumonia Following CHOP Chemotherapy and Filgrastim Use in a Patient with Diffuse Large B-cell Lymphoma.
Wou Young CHUNG ; Min Kwang BYUN ; Jin Hyoung LEE ; Chang Hoon HAHN ; Shin Myung KANG ; Jin Seok KIM ; San Ho CHO ; Young Sam KIM ; Se Kyu KIM ; Joon CHANG ; Sung Kyu KIM ; Moo Suk PARK
Tuberculosis and Respiratory Diseases 2005;59(5):561-565
Bronchiolitis obliterans organizing pneumonia (BOOP) is often diagnosed in patients with pneumonia who respond poorly to antibiotics. BOOP is often idiopathic, and the etiology of the remaining cases has been attributed to a wide range of agents or medical conditions. When a patient develops the clinical symptoms characteristic of BOOP, the medical team must endeavor to determine the etiology of this disease because it can be treated with glucocorticoid and avoidance of the causative agent. In particular, if BOOP is diagnosed during or after chemotherapy for a malignancy, the possible culprit agent can be the anti cancer drugs but other drugs used for supportive care must be also be considered. We report a case of BOOP that arose after CHOP chemotherapy and a filgrastim injection in a patient with a diffuse large B-cell lymphoma.
Anti-Bacterial Agents
;
B-Lymphocytes*
;
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cryptogenic Organizing Pneumonia*
;
Drug Therapy*
;
Humans
;
Lymphoma, B-Cell*
;
Pneumonia
;
Filgrastim
9.A Case of Bronchiolitis Obliterans Organizing Pneumonia with a Solitary Pulmonary Nodule in a Child.
Eun Ji LEE ; Yang Jib KANG ; Hyoung Min CHO ; Yong Wook KIM ; Kyoung Sim KIM ; Eun Young KIM ; Eun Jung YOU ; Ju Hee YOU ; Hoon KOOK
Pediatric Allergy and Respiratory Disease 2012;22(4):433-437
Bronchiolitis obliterans organizing pneumonia (BOOP) is a pulmonary disorder that exhibits various radiographic findings. It often shows bilateral, patched, or ground glass interstitial infiltrate, but a solitary nodular pattern rarely appears. We report a case of an 8-year-old boy suffering from BOOP that showed a single nodular pattern of the lung in the chest radiography. We conclude that when there is a solitary nodule discovered in the lungs of children or adolescence, the differential diagnosis must include BOOP.
Adolescent
;
Bronchiolitis
;
Bronchiolitis Obliterans
;
Child
;
Cryptogenic Organizing Pneumonia
;
Diagnosis, Differential
;
Glass
;
Humans
;
Lung
;
Solitary Pulmonary Nodule
;
Stress, Psychological
;
Thorax
10.A Case of Fulminant Bronchiolitis Obliterans Organizing Pneumonia.
Mi Seon KIM ; Jung Hyun CHANG ; Tai Hee KIM ; Ju Hyun CHA ; Hae Young KIM ; Sun Hee SUNG
Tuberculosis and Respiratory Diseases 1998;45(1):204-212
Bronchiolitis obliterans organizing pneumonia(BOOP) is a type of diffuse interstitial lung disease that has emerged in the past decade as an important cause of acute respiratory illness in adult. Clinically, the entity usually starts with a subacute influenza-like illness, followed by cough, progressive dyspnea, and weight loss. Organized inflammatory polypoid materials predominantly affecting distal bronchioles, alveolar ducts, and peribronchial alveolar spaces are a key pathologic findings. BOOP is characterized by a good response to glucocorticoid and an excellent prognosis. However, there is a subset of BOOP who presents with a fulminant course leading to death or chronic severe fibrosis with marked impairment of lung function. Recently, we have experienced a case of rapidly progressive BOOP, diagnosed by open lung biopsy and showed a reluctant response to corticosteroid.
Adult
;
Biopsy
;
Bronchioles
;
Bronchiolitis Obliterans*
;
Bronchiolitis*
;
Cough
;
Cryptogenic Organizing Pneumonia*
;
Dyspnea
;
Fibrosis
;
Humans
;
Lung
;
Lung Diseases, Interstitial
;
Prognosis
;
Weight Loss